THERALASE TECHNOLOGIES INC (TLT.CA) Stock Balance Sheet
TSX-V:TLT - TSX Venture Exchange - CA88337V1004 - Common Stock - Currency: CAD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 131.80K | 268.80K | 43.90K | 1.51M | 3.69M | |||
| Marketable Securities | N/A | N/A | 273.60K | 140.90K | 16.80K | |||
| Receivables | 669.50K | 711.50K | 598.60K | 436.60K | 300.00K | |||
| Inventories | 515.00K | 545.10K | 658.20K | 485.50K | 566.20K | |||
| Other Current Assets | 85.80K | 58.30K | 198.30K | 70.10K | 440.20K | |||
| Total Current Assets | 1.40M | 1.58M | 1.50M | 2.50M | 5.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 605.20K | 605.80K | 857.90K | 1.11M | 865.90K | |||
| Investments And Advances | N/A | N/A | 920.00K | 553.30K | 71.60K | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | N/A | 0.00 | N/A | N/A | 0.00 | |||
| Total Non-Current Assets | 1.56M | 1.66M | 1.78M | 1.66M | 946.90K | |||
| TOTAL ASSETS | 2.96M | 3.25M | 3.28M | 4.16M | 5.95M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 102.70K | 100.30K | 93.00K | 86.70K | 35.70K | |||
| Accrued Expenses | 481.70K | 523.50K | 302.50K | 254.30K | 342.70K | |||
| Accounts Payable | 1.12M | 362.20K | 682.00K | 340.40K | 496.40K | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 1.70M | 986.00K | 1.08M | 681.50K | 874.80K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 166.90K | 193.60K | 293.90K | 386.90K | 0.00 | |||
| Other Non-Current Liabilities | 0.00 | N/A | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 166.90K | 193.50K | 293.90K | 386.80K | 0.00 | |||
| TOTAL LIABILITIES | 1.87M | 1.18M | 1.37M | 1.07M | 874.80K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -65.79M | -64.44M | -57.02M | -52.81M | -47.99M | |||
| Additional Paid In Capital | 17.77M | 17.58M | 12.49M | 11.37M | 10.94M | |||
| Common Shares | 49.11M | 48.92M | 46.44M | 44.53M | 42.12M | |||
| Shares Outstanding | 248.81M | 247.78M | 228.46M | 216.50M | 204.28M | |||
| Tangible Book Value per Share | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 | |||
| Total Shareholders' Equity | 1.09M | 2.07M | 1.91M | 3.09M | 5.07M | |||
| TOTAL LIABILITIES AND EQUITY | 2.96M | 3.25M | 3.28M | 4.16M | 5.95M | |||
| Statistics | ||||||||
| Debt/Equity | 0.15 | 0.09 | 0.15 | 0.13 | N/A | |||
| Current Ratio | 0.82 | 1.61 | 1.39 | 3.67 | 5.71 | |||
| Return On Assets (ROA) | -150.75% | -131.08% | -139.49% | -125.82% | -74.20% | |||
| Return On Equity (ROE) | -409.16% | -205.86% | -239.89% | -169.28% | -87.00% | |||
All data in CAD , ROIC based on taxRate of 0.28